Cyclerion Therapeutics KRSA

Peter M. Hecht updates its stake in Cyclerion Therapeutics to 27.9%

Form
Schedule 13D/A
Filed
Importance
Notable

Not explained yet; the original is on EDGAR.

Ownership stake disclosure (amended)

Get an email when Cyclerion Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.